{
  "id": 3639461,
  "title": "GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock",
  "url": "https://urgent.news/2026/08/27/goodrx-nasdaq-gdrx-10-owner-francisco-partners-sells-5-48m-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-27T01:50:09.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/goodrx-nasdaqgdrx-10-owner-francisco-partners-sells-548m-in-stock-93CH-4878228"
  },
  "original_language": "en",
  "account": "Francisco Partners, a prominent investor in GoodRx Holdings, Inc. (NASDAQ:GDRX), recently disposed of a substantial $5.48 million worth of Class A Common Stock over several days in late August 2026. The sales occurred through two investment entities, Francisco Partners IV, L.P., and Francisco Partners IV-A, L.P., which together sold a total of 1,034,472 shares. The transactions took place at a weighted average price of $3.462 per share, with individual shares being sold between $3.425 and $3.50 per share. On August 25, 2026, the investors sold an additional 127,273 shares at a slightly lower average price of $3.4449 per share. The following day, August 26, 2026, the investors conducted their largest single transaction, selling 423,688 shares at $3.5125 per share. These sales marked a significant reduction in Francisco Partners' ownership stake in GoodRx, as the company's shares had surged by 95% over the previous six months, currently trading at $3.65 with a market capitalization of $1.25 billion. Despite the significant reduction in ownership, GoodRx Holdings reported strong second-quarter results, surpassing revenue expectations and raising its full-year 2026 outlook.",
  "summary": null,
  "key_points": [
    "Francisco Partners sold $5.48 million of GoodRx stock in late August 2026.",
    "Investors from Francisco Partners IV and IV-A sold 1,034,472 shares.",
    "Largest sale of 423,688 shares occurred on August 26 at $3.5125 per share."
  ],
  "editors_take": "Francisco Partners' sale of a $5.48 million stake in GoodRx signals a significant reduction in its ownership, following a 95% surge in the company's shares over the previous six months.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}